Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Rita Bellagamba

A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART

scientific article

Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir

article

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome

article

Dynamics of NRTI Resistance Mutations during Therapy Interruption

article

Genetic divergence of HIV-1 B subtype in Italy over the years 2003-2016 and impact on CTL escape prevalence

scientific article published in Scientific Reports

Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.

scientific article published on 18 July 2016

Immune Status and Serial Quantiferon-TB Gold In-Tube Screening for LatentMycobacterium tuberculosisInfection Among HIV-Infected Persons in a Country With a Low Tuberculosis Incidence

scientific article published on 26 January 2015

Impact of pre-therapy viral load on virological response to modern first-line HAART.

scientific article published on 23 January 2013

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort

scientific article published on 13 April 2004

Plasma HIV RNA Decline and Emergence of Drug Resistance Mutations among Patients with Multiple Virologic Failures Receiving Resistance Testing-Guided HAART

article

Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy

scientific article

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

scientific article

Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure

scientific article published in May 2008

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

article

Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort

scientific article published on 18 June 2015

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study

scientific article

The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro

scientific article published on 25 July 2016

Use of novel antiretroviral agents in rescue regimens: a case of early virological failure to raltegravir

scientific article published in March 2010

gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure

scientific article published in October 2007